DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. - Wikidata - awgldk - TriplyDB

DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration.

DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration.

http://www.wikidata.org/entity/Q40587927

about

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.Intracellular targeting with engineered proteins Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection Chemically activatable viral capsid functionalized for cancer targeting Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway Oral vaccination: where we are?Optimization and delivery of plasmid DNA for vaccination.Vaccine delivery using nanoparticles.Hepatitis E vaccine.Biological gene delivery vehicles: beyond viral vectors.Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Developments in virus-like particle-based vaccines for HIV.Nodavirus-based biological container for targeted delivery system.Oral delivery of nanoparticle-based vaccines.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Mucosal vaccine delivery: Current state and a pediatric perspective Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection.DNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagents.HIV infection and specific mucosal immunity: workshop 4B.Structural characterization of site-modified nanocapsid with monodispersed gold clusters.Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.

P2860

Q22241377-1A33A52E-64A5-443E-B4B3-DC8F7A3D90D7 Q24816925-6D4C3B73-3898-4D3F-A91A-6283A02714A0 Q26740106-2C73C743-3218-4141-B6F0-E844AABE0E79 Q27001897-18C41CCA-8AA1-4210-A505-9572BCEEA3F8 Q28830058-19B50D45-9B23-4C42-ACD0-542198B34611 Q34045644-6FF4D245-C16A-45E0-A60E-684E4ACF90E1 Q34236742-D1BE8750-D698-4527-AFBE-C9121A82A3BE Q34660422-8D19B31A-0CDF-4117-B80C-F565701DE675 Q36690285-8AD42811-30BA-46BD-928B-FE213CFCCA98 Q36712817-51C6A4A6-5865-4A37-9568-F67604F8E951 Q37278231-88D98E18-AC54-47DD-90DC-562EF0B1E6EA Q37412239-FCFFDE49-CC71-451A-9C8A-BC039B9E7988 Q37834097-66C623B1-1E48-4B15-AEA1-A51E0B406B31 Q37896455-065F45B3-23F6-4B0A-9F9D-141CA85C9839 Q37951525-1FD0C563-0B41-4A1F-ACAC-91BF128B36DB Q38081965-B351388E-02E7-4051-B949-B6F179222453 Q38192663-36FC69EA-A54D-4A4B-AA4B-8706E84AD1F8 Q38243119-5C25496F-3E47-48D4-90EC-4562636B6D87 Q38618258-AA06CD5F-09B4-49AE-9A44-2820A0F68FA1 Q38727453-B6855DF8-1154-43B8-B07E-2416453A1D6C Q38950048-5C06697A-E9CF-4B4E-9C05-D28618066CC8 Q39079605-B4DAB92B-495E-41B1-A2E3-5F9E297F60E1 Q41666565-B8B5338B-43E8-401A-810F-A190D4545F52 Q43994786-535C050D-004A-4CED-A062-04C26E077EF1 Q46183687-E8850466-442B-4B8A-BF66-7C73710456B0 Q47276928-D4B46FF1-54CF-446E-88DB-024C0E07217A

P2860

DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration.

http://www.wikidata.org/entity/Q40587927

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

DNA vaccine-encapsulated virus ...... ponses by oral administration.

@en

type

label

DNA vaccine-encapsulated virus ...... ponses by oral administration.

@en

prefLabel

DNA vaccine-encapsulated virus ...... ponses by oral administration.

@en

P1433

Q40587927-B08E025B-CD15-436D-8E1D-DFE901A00E4F

P1476

Q40587927-20400E12-817A-4837-B632-A696E4A011C6

P2093

Q40587927-0D87CA90-CF17-452B-9FB0-BB534971A57F

Q40587927-184AFC54-13A1-4A32-8BEC-FED06E49FB60

Q40587927-3FA23DBB-409D-4D8B-901A-A6FFEE05D0B3

Q40587927-4C818CDF-D87B-438C-8E1F-A02D47732398

Q40587927-59655075-46E6-490A-AD17-DFF3BC22F162

Q40587927-97D79AEE-97B4-4755-8124-77FE6EABAADB

Q40587927-BA9EED41-D66F-4FDD-AA6C-B9849D4B2527

Q40587927-E7266404-2E4E-4132-BADF-B7E0D7942B2C

P2860

Q40587927-0E0AF927-FCE1-4425-8439-E69BD90CCF80

Q40587927-12657E95-9CC2-408F-B172-11FBB58BEC0A

Q40587927-23D63477-739D-4F49-A3A6-4B393221AAC1

Q40587927-268D3708-99DC-43EC-A1A0-52497CC6FFD1

Q40587927-371FEE55-79AE-454A-8217-DADEA82DA0CC

Q40587927-3B709445-0696-41B4-97D0-206DE4A85CBB

Q40587927-4748B4D2-6456-4220-A0D5-56B955606109

Q40587927-5C32B4A0-2C3F-4A7D-BCF0-1F6752B2D3AB

Q40587927-8975412E-3F0D-4D4C-BC22-66ED1D56BD27

Q40587927-92662924-8F75-407A-8839-E4F5C2D2C813

P2888

Q40587927-72AFEF2E-932D-4C67-9073-C5162335CE9C

P304

Q40587927-6D8CB593-C6C9-4944-B5C4-6A50DE856997

P31

Q40587927-FD04C243-219B-4484-BC31-AA24C5BB5690

P356

Q40587927-EB9ABF6F-2EA2-43CB-9FAE-B91AECE8283D

P433

Q40587927-F28F2909-F9E7-427D-8373-71502DE92366

P478

Q40587927-39E8735E-B3CB-4148-8798-0E23B409CCB4

P577

Q40587927-B42F15F0-EA18-40F4-8C7C-1085317628FB

P5875

Q40587927-BAE601BD-3529-4C14-A082-FD33B773DB26

P6179

Q40587927-F04890FB-2733-4875-B165-5D97D4B8AEB8

P698

Q40587927-43CBE876-FD8D-4DEC-89F0-C6E9F56EC013

P356

P1433

P1476

DNA vaccine-encapsulated virus ...... ponses by oral administration.

@en

P2093

Kusagawa S

http://www.w3.org/2001/XMLSchema#string

Li TC

http://www.w3.org/2001/XMLSchema#string

Miyamura T

http://www.w3.org/2001/XMLSchema#string

Niikura M

http://www.w3.org/2001/XMLSchema#string

Takamura S

http://www.w3.org/2001/XMLSchema#string

Takebe Y

http://www.w3.org/2001/XMLSchema#string

Takeda N

http://www.w3.org/2001/XMLSchema#string

Yasutomi Y

http://www.w3.org/2001/XMLSchema#string

P2860

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Efficient gene transfer into human hepatocytes by baculovirus vectors

Modulation of immune responses following antigen administration by mucosal route.

M cell-targeted DNA vaccination

Vaccination strategies for mucosal immune responses

Hepatitis E: an overview.

Sendai virus-based production of HIV type 1 subtype B and subtype E envelope glycoprotein 120 antigens and their use for highly sensitive detection of subtype-specific serum antibodies.

Gene transfer mediated by alpha2-macroglobulin.

In vitro gene transfer using human papillomavirus-like particles.

Gene therapy vectors as drug delivery systems.

P2888

P304

628-635

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3302193

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7645365

http://www.w3.org/2001/XMLSchema#string

P6179

1023586846

http://www.w3.org/2001/XMLSchema#string

P698

14973544

http://www.w3.org/2001/XMLSchema#string